MX2009001230A - Implantes subcutaneos que liberan un principio activo durante un periodo de tiempo extendido. - Google Patents
Implantes subcutaneos que liberan un principio activo durante un periodo de tiempo extendido.Info
- Publication number
- MX2009001230A MX2009001230A MX2009001230A MX2009001230A MX2009001230A MX 2009001230 A MX2009001230 A MX 2009001230A MX 2009001230 A MX2009001230 A MX 2009001230A MX 2009001230 A MX2009001230 A MX 2009001230A MX 2009001230 A MX2009001230 A MX 2009001230A
- Authority
- MX
- Mexico
- Prior art keywords
- subcutaneous implants
- time
- extended period
- active principle
- plga
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Organic Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Los implantes subcutáneos obtenidos por extrusión que contienen un ingrediente activo dispersado en una matriz PLGA obtenidos moliendo un producto extruído que consiste de una mezcla de: al menos dos PLGA que tienen diferentes rangos de ácido láctico/glicólico molares y diferentes pesos moleculares promedio de peso, o una PLGA y PLA que tienen diferente peso molecular promedio.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT001538A ITMI20061538A1 (it) | 2006-08-02 | 2006-08-02 | Impianti sottocutanei in grado di rilasciare il principio attivo per un periodo prolungato di tempo |
PCT/EP2007/057967 WO2008015236A1 (en) | 2006-08-02 | 2007-08-01 | Subcutaneous implants releasing an active principle over an extended period of time |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009001230A true MX2009001230A (es) | 2009-04-28 |
Family
ID=37776598
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009001230A MX2009001230A (es) | 2006-08-02 | 2007-08-01 | Implantes subcutaneos que liberan un principio activo durante un periodo de tiempo extendido. |
Country Status (18)
Country | Link |
---|---|
US (1) | US20100062037A1 (es) |
EP (1) | EP2054029B9 (es) |
JP (1) | JP2009545563A (es) |
KR (1) | KR20090048463A (es) |
CN (1) | CN101522170B (es) |
AT (1) | ATE471711T1 (es) |
AU (1) | AU2007280395A1 (es) |
BR (1) | BRPI0714820A2 (es) |
CA (1) | CA2659440A1 (es) |
DE (1) | DE602007007338D1 (es) |
EA (1) | EA015795B1 (es) |
ES (1) | ES2347716T3 (es) |
HK (1) | HK1131547A1 (es) |
IT (1) | ITMI20061538A1 (es) |
MX (1) | MX2009001230A (es) |
PL (1) | PL2054029T3 (es) |
PT (1) | PT2054029E (es) |
WO (1) | WO2008015236A1 (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9114238B2 (en) | 2007-04-16 | 2015-08-25 | Corium International, Inc. | Solvent-cast microprotrusion arrays containing active ingredient |
CN104288844A (zh) * | 2007-10-18 | 2015-01-21 | 杜雷科特公司 | 具有可控堆积密度的可生物降解植入物 |
JP6327852B2 (ja) | 2010-05-04 | 2018-05-23 | コリウム インターナショナル, インコーポレイテッド | 微小突起アレイを使用した副甲状腺ホルモンの経皮送達のための方法及びデバイス |
WO2013019280A1 (en) * | 2011-08-04 | 2013-02-07 | Flexion Therapeutics | Corticosteroids for the treatment of joint pain |
AU2013364053B2 (en) | 2012-12-21 | 2018-08-30 | Corium Pharma Solutions, Inc. | Microarray for delivery of therapeutic agent and methods of use |
BR122020006959B1 (pt) | 2013-03-12 | 2022-04-26 | Corium, Inc | Aplicador de microprojeções |
BR112015022625B1 (pt) | 2013-03-15 | 2023-01-31 | Corium, Inc | Aparelho de microestrutura para entrega de agente terapêutico |
CA2903459C (en) | 2013-03-15 | 2024-02-20 | Corium International, Inc. | Multiple impact microprojection applicators and methods of use |
JP2016514133A (ja) | 2013-03-15 | 2016-05-19 | コリウム インターナショナル, インコーポレイテッド | ポリマーを含まない微細構造物を含むマイクロアレイ、製造方法および使用方法 |
CN103446041B (zh) * | 2013-08-27 | 2015-06-10 | 青岛东辉医药科技发展有限公司 | 一种亮丙瑞林缓控释药棒及其制备方法 |
EP3188714A1 (en) | 2014-09-04 | 2017-07-12 | Corium International, Inc. | Microstructure array, methods of making, and methods of use |
WO2017004067A1 (en) | 2015-06-29 | 2017-01-05 | Corium International, Inc. | Microarray for delivery of therapeutic agent, methods of use, and methods of making |
RU2612826C1 (ru) * | 2015-12-30 | 2017-03-13 | Артур Магомедович Омаров | Блок имплантата для реконструкции дефектной части альвеолярного отростка и способ реконструкции дефектной части альвеолярного отростка |
DE102018127200B3 (de) * | 2018-10-31 | 2019-07-25 | Andreas Haas | Implantat zum subkutanen implantieren |
GB202106973D0 (en) * | 2021-05-14 | 2021-06-30 | Locate Bio Ltd | Osteoconductive implant material with BMP-2 delivery |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9211268D0 (en) * | 1992-05-28 | 1992-07-15 | Ici Plc | Salts of basic peptides with carboxyterminated polyesters |
JPH08157370A (ja) * | 1994-12-06 | 1996-06-18 | Banyu Pharmaceut Co Ltd | フィナステリド含有徐放性組成物 |
US20030211157A1 (en) * | 1996-05-06 | 2003-11-13 | Simon David Lew | Semi-sol delivery blend for water soluble molecules |
US5817343A (en) * | 1996-05-14 | 1998-10-06 | Alkermes, Inc. | Method for fabricating polymer-based controlled-release devices |
AU742372B2 (en) * | 1997-06-04 | 2002-01-03 | Debio Recherche Pharmaceutique S.A. | Implants for controlled release of pharmaceutically active principles and method for making same |
IT1304152B1 (it) * | 1998-12-10 | 2001-03-08 | Mediolanum Farmaceutici Srl | Composizioni comprendenti un peptide ed acido polilattico-glicolicoatte alla preparazione di impianti sottocutanei aventi un prolungato |
CN100592904C (zh) * | 2003-06-26 | 2010-03-03 | 梅迪奥拉努姆制药有限公司 | 具有有效成分的有限起始释放及随后线性变化延长释放的皮下植入物 |
US20050244463A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Sustained release intraocular implants and methods for treating ocular vasculopathies |
-
2006
- 2006-08-02 IT IT001538A patent/ITMI20061538A1/it unknown
-
2007
- 2007-08-01 EP EP07788135A patent/EP2054029B9/en not_active Not-in-force
- 2007-08-01 JP JP2009522273A patent/JP2009545563A/ja active Pending
- 2007-08-01 ES ES07788135T patent/ES2347716T3/es active Active
- 2007-08-01 EA EA200900246A patent/EA015795B1/ru not_active IP Right Cessation
- 2007-08-01 CN CN2007800364398A patent/CN101522170B/zh not_active Expired - Fee Related
- 2007-08-01 PT PT07788135T patent/PT2054029E/pt unknown
- 2007-08-01 AT AT07788135T patent/ATE471711T1/de active
- 2007-08-01 AU AU2007280395A patent/AU2007280395A1/en not_active Abandoned
- 2007-08-01 CA CA002659440A patent/CA2659440A1/en not_active Abandoned
- 2007-08-01 BR BRPI0714820-8A patent/BRPI0714820A2/pt not_active IP Right Cessation
- 2007-08-01 MX MX2009001230A patent/MX2009001230A/es active IP Right Grant
- 2007-08-01 WO PCT/EP2007/057967 patent/WO2008015236A1/en active Application Filing
- 2007-08-01 KR KR1020097003185A patent/KR20090048463A/ko not_active Application Discontinuation
- 2007-08-01 DE DE602007007338T patent/DE602007007338D1/de active Active
- 2007-08-01 PL PL07788135T patent/PL2054029T3/pl unknown
- 2007-08-01 US US12/309,771 patent/US20100062037A1/en not_active Abandoned
-
2009
- 2009-11-02 HK HK09110172.0A patent/HK1131547A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR20090048463A (ko) | 2009-05-13 |
PL2054029T3 (pl) | 2010-11-30 |
HK1131547A1 (en) | 2010-01-29 |
EP2054029A1 (en) | 2009-05-06 |
DE602007007338D1 (de) | 2010-08-05 |
AU2007280395A1 (en) | 2008-02-07 |
US20100062037A1 (en) | 2010-03-11 |
EA200900246A1 (ru) | 2009-06-30 |
CN101522170A (zh) | 2009-09-02 |
BRPI0714820A2 (pt) | 2013-05-21 |
ATE471711T1 (de) | 2010-07-15 |
ITMI20061538A1 (it) | 2008-02-03 |
WO2008015236A1 (en) | 2008-02-07 |
WO2008015236A8 (en) | 2008-06-05 |
EP2054029B1 (en) | 2010-06-23 |
EP2054029B9 (en) | 2011-02-02 |
CA2659440A1 (en) | 2008-02-07 |
ES2347716T3 (es) | 2010-11-03 |
EA015795B1 (ru) | 2011-12-30 |
PT2054029E (pt) | 2010-10-04 |
CN101522170B (zh) | 2013-04-24 |
JP2009545563A (ja) | 2009-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1131547A1 (en) | Subcutaneous implants releasing an active principle over an extended period of time | |
WO2010005723A3 (en) | Drug loaded polymeric nanoparticles and methods of making and using same | |
WO2012054923A3 (en) | Therapeutic nanoparticles with high molecular weight copolymers | |
NZ607797A (en) | Corticosteroids for the treatment of joint pain | |
WO2007130134A3 (en) | Controlled release microparticles | |
JP2010514474A5 (es) | ||
WO2008098019A3 (en) | Polymer formulations for delivery of bioactive agents | |
WO2012080383A3 (en) | Personal care compositions including aqueous compositions of viscoelastic surfactants and hydrophobically modified polymers | |
WO2007041584A3 (en) | Implantable sensors, implantable pumps, and anti-scarring drug combinations | |
GB2430157A (en) | Personal care products and methods for inhibiting the adherence of flora to skin | |
EP1837042A3 (en) | Implantable device formed from polymer blends having modified molecular structures | |
ATE382337T1 (de) | Bioabsorbierbare pharmazeutische zusammensetzung enthaltend einen plga-copolymer | |
NO20050419L (no) | Farmasoytiske blandinger av legemidler og polymerer av halv-orden | |
WO2010061288A3 (en) | Polymeric pharmaceutical dosage form in sustained release | |
NZ600156A (en) | Degradable removable implant for the sustained release of an active compound | |
MX2007007099A (es) | Implante formado in situ para animales. | |
WO2018213815A3 (en) | Synthetic quorum-regulated lysis | |
WO2010043710A3 (en) | An implantable medical device | |
WO2008015232A8 (en) | Subcutaneous implants releasing an active principle over an extended period of time | |
JP2011508791A5 (es) | ||
UA92604C2 (ru) | Композиция стансопорфина с физиологической осмотической концентрацией и ее применение | |
GEP20125618B (en) | Biodegradable copolymers of poly (ester urea) and method for obtaining same | |
EP2462960A3 (en) | Polymer for controlling delivery of bioactive agents and method of use | |
TW200640472A (en) | Solid pharmaceutical composition comprising telithromycin | |
TW200509980A (en) | Parasiticidal composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |